PSTV insider transaction filings

PLUS THERAPEUTICS, INC. — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-01. Screen PSTV transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-014ANDREWS RONALD ASBURY — DirectorOption exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-07-014Sims Andrew John Hugh MacIntyre — Chief Financial OfficerOption exercise (M): 1,533 @ $0 · Option exercise (M): 1,165 @ $0 · Option exercise (M): 287 @ $0 · Option exercise (M): 1,533 (derivative) @ $0 · Option exercise (M): 1,165 (derivative) @ $0 · Option exercise (M): 287 (derivative) @ $0EDGAR
2026-07-014Hawkins Richard J — DirectorOption exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-07-014Guse Kyle — DirectorOption exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-07-014van Es-Johansson An — DirectorOption exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-07-014HEDRICK MARC H — Chief Executive Officer, DirectorOption exercise (M): 6,387 @ $0 · Option exercise (M): 8,066 @ $0 · Option exercise (M): 1,986 @ $0 · Option exercise (M): 6,387 (derivative) @ $0 · Option exercise (M): 8,066 (derivative) @ $0 · Option exercise (M): 1,986 (derivative) @ $0EDGAR
2026-07-014Clowes Howard — DirectorOption exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-05-184van Es-Johansson An — DirectorGrant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0EDGAR
2026-05-184Hawkins Richard J — DirectorGrant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0EDGAR
2026-05-184Guse Kyle — DirectorGrant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0EDGAR
2026-05-184Clowes Howard — DirectorGrant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0EDGAR
2026-05-184ANDREWS RONALD ASBURY — DirectorGrant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 1,600 (derivative) @ $0EDGAR
2026-05-184Sims Andrew John Hugh MacIntyre — Chief Financial OfficerGrant/award (A): 3,443 (derivative) @ $0 · Grant/award (A): 3,443 (derivative) @ $0EDGAR
2026-05-184HEDRICK MARC H — Chief Executive Officer, DirectorGrant/award (A): 23,834 (derivative) @ $0 · Grant/award (A): 23,834 (derivative) @ $0EDGAR
2026-04-224Daniels Eric Joseph — Chief Development OfficerGrant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-04-014Sims Andrew John Hugh MacIntyre — Chief Financial OfficerOption exercise (M): 38,323 @ $0 · Option exercise (M): 29,129 @ $0 · Option exercise (M): 38,323 (derivative) @ $0 · Option exercise (M): 29,129 (derivative) @ $0EDGAR
2026-04-014HEDRICK MARC H — Chief Executive Officer, DirectorOption exercise (M): 159,681 @ $0 · Option exercise (M): 201,632 @ $0 · Option exercise (M): 159,681 (derivative) @ $0 · Option exercise (M): 201,632 (derivative) @ $0EDGAR
2026-02-274Sims Andrew John Hugh MacIntyre — Chief Financial OfficerGrant/award (A): 349,542 (derivative) @ $0 · Grant/award (A): 349,541 (derivative) @ $0EDGAR
2026-02-274HEDRICK MARC H — Chief Executive Officer, DirectorGrant/award (A): 2,419,582 (derivative) @ $0 · Grant/award (A): 2,419,582 (derivative) @ $0EDGAR
2026-01-024HEDRICK MARC H — Chief Executive Officer, DirectorOption exercise (M): 159,681 @ $0 · Option exercise (M): 159,681 (derivative) @ $0EDGAR
2026-01-024Sims Andrew John Hugh MacIntyre — Chief Financial OfficerOption exercise (M): 38,323 @ $0 · Option exercise (M): 38,323 (derivative) @ $0EDGAR
2025-11-054Sims Andrew John Hugh MacIntyre — Chief Financial OfficerPurchase (P): 20,000 @ $0.51EDGAR
2025-10-034HEDRICK MARC H — Chief Executive Officer, DirectorOption exercise (M): 159,681 @ $0 · Option exercise (M): 159,681 (derivative) @ $0EDGAR
2025-10-034Sims Andrew John Hugh MacIntyre — Chief Financial OfficerOption exercise (M): 38,323 @ $0 · Option exercise (M): 38,323 (derivative) @ $0EDGAR
2025-10-034/AHEDRICK MARC H — Chief Executive Officer, DirectorGrant/award (A): 5,748,506 (derivative) @ $0 · Grant/award (A): 1,916,168 (derivative) @ $0EDGAR
2025-10-034/ASims Andrew John Hugh MacIntyre — Chief Financial OfficerGrant/award (A): 1,379,636 (derivative) @ $0 · Grant/award (A): 459,878 (derivative) @ $0EDGAR
2025-08-254Lenk Robert P — DirectorPurchase (P): 110,000 @ $0.49EDGAR
2025-08-154Guse Kyle — DirectorGrant/award (A): 297,794 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-08-154HEDRICK MARC H — Chief Executive Officer, DirectorGrant/award (A): 5,748,506 (derivative) @ $0 · Grant/award (A): 1,916,168 (derivative) @ $0EDGAR
2025-08-154Hawkins Richard J — DirectorGrant/award (A): 397,794 (derivative) @ $0EDGAR
2025-08-154Clowes Howard — DirectorGrant/award (A): 297,794 (derivative) @ $0EDGAR
2025-08-154Lenk Robert P — DirectorGrant/award (A): 297,794 (derivative) @ $0EDGAR
2025-08-154Sims Andrew John Hugh MacIntyre — Chief Financial OfficerGrant/award (A): 1,379,636 (derivative) @ $0 · Grant/award (A): 459,878 (derivative) @ $0EDGAR
2025-08-154van Es-Johansson An — DirectorGrant/award (A): 297,794 (derivative) @ $0EDGAR
2025-02-204Hawkins Richard J — DirectorGrant/award (A): 40,122 (derivative) @ $0EDGAR
2025-02-204Clowes Howard — DirectorGrant/award (A): 40,122 (derivative) @ $0EDGAR
2025-02-204Lenk Robert P — DirectorGrant/award (A): 40,122 (derivative) @ $0EDGAR
2025-02-204van Es-Johansson An — DirectorGrant/award (A): 40,122 (derivative) @ $0EDGAR
2025-02-204HEDRICK MARC H — Chief Executive Officer, DirectorGrant/award (A): 400,489 (derivative) @ $0EDGAR
2025-02-204Petersen Greg — DirectorGrant/award (A): 40,122 (derivative) @ $0EDGAR
2025-02-204Sims Andrew John Hugh MacIntyre — Chief Financial OfficerGrant/award (A): 60,020 (derivative) @ $0EDGAR

Recent 8-K events — PLUS THERAPEUTICS, INC.

FiledFormItems reportedSource
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-218-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-028-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PSTV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →